MAKE AN APPOINTMENT NOW!
ABOUT ME
Dr. Suvadip Chakrabarti MCh (Surgical Oncology) is one of the Best Surgical Oncologists in Kolkata, West Bengal, India. In Kolkata, he is HOD, Department of Surgical Oncology, AMRI Mukundapur. He is also associated as a visiting Consultant in the Department of Surgical Oncology with Medica Super-specialty Hospital, Kolkata and Ruby Cancer Center, Kolkata. He is the chief advisor of Surgical Oncology of the upcoming BIMS-BCF Cancer center, Burdwan.
Let us help ourselves with a brief outfit of his entire journey and triumphs.
He has completed his MBBS from Bangalore, Karnataka in 2008. Surgery being his option for further studies, he completed his Masters in Surgery from Mumbai, Maharashtra in 2012. Through an on-look of ongoing incidents, he felt the urge to utilize his talent in the struggle against Cancer, which takes regular toll of mortal lives. As a follow-up of his desire to negate the vile of cancer, he undertook the MCh program in Surgical Oncology and completed the same from Indore in 2015.
Our state and country feel blessed with the services of such talented and dedicated MCH trained Surgical Oncologist of Eastern India.
Dr. Suvadip Chakrabarti has been the first from Central India to pass out as MCh trained Surgical Oncologist from Devi Ahilya Vishyavidalaya University run by the Government of Madhya Pradesh.
NOTICE
SURGICAL EXPERTISE
HEAD & NECK MALIGNANCY
Oncology at Head and Cervical positions is performed in a variety of forms. These statuses can be enumerated..
THYROID MALIGNANCY
This type of disease may initially appear as a lump at the cervical position that grows fast.
BREAST CANCER
The best shot of treatment is available with the latest screening diagnosis and treatment.
GYNAE ONCOLOGY
Gynae Oncology is associated with the surgical oncology related to Gynaecological factors.
CRS+HIPEC SURGERY
Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy
The paradigm of cytoreductive surgery or CRS has been induced with hyper-thermic intraperitoneal chemotherapy (HIPEC) to treat resectable peritoneal carcinomatosis in most effective way. Use of this technology has also helped in boosting the chances of survival for patients.
GI MALIGNANCY
In medicine, commonly used abbreviation for gastrointestinal, referring collectively to the stomach and the small and large intestine.
STOMACH
Stomach cancer does not become prevalent until it reaches a more advanced stage. At the advanced stage, such cancer shows various symptoms.
COLON
Colon is one of the most important organs in the digestive systems. It helps in removing solid wastes from the body.
RECTUM CANCER
Such cancers are seen to develop over a period of time. It arises from pre-cancerous colon polyps that grow and turn into cancer cell.
LATEST BLOGS
Make an Appointment Now!
HAPPY & THANKFUL PATIENTS
Sunil K. Nagar
I have found Dr. Suvadip very helpful over the years. He is warm and friendly and genuinely interested in addressing his patient’s problems. A few years ago, I consulted one of my medical doctors regarding a skin condition I was skeptical about and when I told Dr. Suvadip about my former doctor’s diagnosis report, he confirmed me that he was right with disease detection and was very impressed. I recommend him to all my staff, family and friends.
Natasha S.
The experience with Dr. Suvadip was amazing. It was the most fruitful 11/2 hours I have ever spent with a medical practitioner. He has answered my question that has been haunting me for years. So, thank you for providing me the info. I will definitely continue to visit him for further consultation.
G.C. Paik
An overwhelming experience with Dr. Suvadip! I will highly recommend him to anyone wishing to improve their overall health.
DISCLAIMER
Oncology is an ever evolving field of medicine and is matter of research and development. The author per say does not claim the following to be guidelines of practice in oncology. These are part of patient awareness initiative by Dr. Suvadip Chakrabarti MCh (Surgical Oncology) to educate people at large of various options in Oncology. It should not be taken to be practice guidelines.
